Our latest paper in ⁦Cell Reports⁩ on the impact of #stress on iNKT and MAIT cells with implications for #cancer, #infection, #immunosuppression & #immunotherapy. ⁦Cell Press⁩ ⁦Schulich WesternU⁩ ⁦⁦⁦⁦⁦⁦@CellsMait⁩ cell.com/cell-reports/f…

Protection of the endothelial glycocalyx in vascular allografts via the enzymatic ligation of immunosuppressive glycopolymers prevents allograft rejection after transplantation in the absence of systemic immunosuppression. rdcu.be/cvdTB

UBC Microbiology and Immunology is hiring! Tier I Canada Research Chair in Infectious Disease and Immunity. I love being part of this Department - come join us! UBC Dept of Microbiology and Immunology microbiology.ubc.ca/faculty-opport…

Dear Twitterverse, we have an opportunity to join the lab! See 👇 and consider being part of the many cool, well-funded projects we have going on! ⁦Toronto General Hospital Research Institute⁩ ⁦UHN Research⁩ ⁦University of Toronto⁩ ⁦UofT Vascular Surgery⁩ ⁦Peter Munk Cardiac Centre⁩ recruitingsite.com/csbsites/uhnca…

A new review. Subsets of #islet immune cells support dual roles in immune regulation and tissue regeneration #diabetes #T1D Diabetologia Megan Levings Bruce Verchere link.springer.com/article/10.100…

This review discusses the potential for immunoregulatory macrophages, innate lymphoid cells and regulatory T cells to promote beta cell regeneration in #type1diabetes Megan Levings, Bruce Verchere, @sarah_crome, Mahdis Monajemi, Sarah Colpitts, Matt B bit.ly/3zxxMBD

New: Suppression of Human Dendritic Cells by Regulatory T Cells bio-protocol.org/e4217 by Qing Huang, Avery J. Lam, @dom_boardman1, Nicholas A. J. Dawson, and Megan Levings University of British Columbia BC Children's Hospital Research Institute #immunology #protocol Science Translational Medicine

This study assessed the safety of ustekinumab, a #MonoclonalAntibody used in #psoriasis, in a small cohort of young #type1diabetes patients Here, the researchers report on safety & immune-mechanistic data 👉buff.ly/3wZkzSo

We’re #hiring a Clinical Trial Manager! This position will manage the ongoing UST1D2 clinical trial. The incumbent will be involved in a full range of research activities and will report to the Principal Investigator, Dr. Jan Dutz. More: bcchr.info/3sM43T5

Results from the first-in-human trial of implanted encapsulated pluripotent stem-cell-derived pancreatic endoderm cells to treat #type1diabetes is now published in Cell Stem Cell. Was great to be part of the trial immune research team BC Children's Hospital Research Institute with Megan Levings and Kirsten Ward-Hartstonge.

Dr. @Dom_Boardman1 and a team in Dr. Megan Levings' (Megan Levings) lab developed the first chimeric antigen receptor (CAR) to target a microbial antigen! 🦠 They aim to develop an optimized #Treg #CellTherapy to treat inflammatory and autoimmune diseases. bit.ly/3ZltOKy

Check out our GVHD protocol: "Modelling Graft-Versus-Host Disease in Mice Using Human Peripheral Blood Mononuclear Cells" Bio-protocol from Megan Levings lab. @dom_boardman1 Katie MacDonald Majid Mojibian

📢JOB ALERT 🥁 UBC Dept of Microbiology and Immunology is looking for FACULTY POSITIONS IN ANTIMICROBIAL RESISTANCE The positions will start no earlier than July 1, 2023 #microbiology #immunology #Vancouver #Canada ▶️ Apply now details below 👇🏽 microbiology.ubc.ca/faculty-opport…

Insulin B peptide-MHC class II-specific chimeric antigen 1 receptor-Tregs prevent autoimmune diabetes biorxiv.org/cgi/content/sh… #biorxiv_immuno

We are looking to hire a research coordinator to join my lab at UBC and the team at IBD Centre of BC. The position will involve supporting our team to undertake research focusing on optimising medical and dietary therapies for IBD patients. Please retweet! ubc.wd10.myworkdayjobs.com/ubcstaffjobs/j…

Looking for a postdoc in immunology? Excited to work on human T cells, #organoids and/or clinical studies? Then apply to join my team Doherty Institute UniMelb MDHS, applications accepted until July 12th via the link. #postdocjobs #immunology #Melbourne jobs.unimelb.edu.au/en/job/913019/…

Beautiful work by Megan Levings Brian T. Fife showing how potent antigen-specific #Tregs can be in cellular biotherapy of #autoimmunity !👉Insulin B peptide-MHC class II-specific chimeric antigen receptor-Tregs prevent autoimmune diabetes in mice. jci.org/articles/view/…

We are ✨hiring✨ not one, not two, but three new faculty positions in UBC School of Biomedical Engineering! The focuses are on cell therapies for autoimmune diseases, neuroengineering and immunoengineering. Passion for pranking Peter Zandstra on April Fool's desired, but not required. Please RT (RX? Idk)!

In this study in the current issue of Transplantation, Megan Levings et al. describe a novel mouse model for studying human islet rejection while avoiding xenograft-versus-host disease. #VisualAbstract #TransplantTwitter bit.ly/3squG4i

Research by the Megan Levings lab team reveals a new dimension of CAR-#Treg biology, and has important implications for the design of CARs for clinical use in Tregs. #allograft Learn more in JCI insight: 📗 bit.ly/46uRezV